Pharmaceutical News

RSS

Vitamin D supplements ineffective in preventing osteoporosis, finds study

Taking vitamin D supplements does not improve bone mineral density at the total hip, spine, forearm, or in the body as a whole, a large meta-analysis involving more than 4000 healthy adults published in The Lancet has found.

11 Oct 2013

Scientists introduce new approach to the production of synthetic heparin mimetics

One of the risks of any large operation is the occurrence of blood clots. To prevent this, patients are routinely given the anticoagulant heparin or related drugs. American scientists have now introduced a new approach to the production of synthetic heparin mimetics with better activity profiles.

11 Oct 2013

Study: Statin do not improve VAP outcomes

Laurent Papazian, M.D., Ph.D., of H-pital Nord, Marseille, France, and colleagues conducted a study to determine whether statin therapy decreased day-28 mortality among intensive care unit patients with ventilator-associated pneumonia.

11 Oct 2013

TSRI scientists discover viable strategy for weight loss in people

Scientists at The Scripps Research Institute have discovered key details of a brain-to-body signaling circuit that enables roundworms to lose weight independently of food intake. The weight-loss circuit is activated by combined signals from the worm versions of the neurotransmitters serotonin and adrenaline, and there are reasons to suspect that it exists in a similar form in humans and other mammals.

11 Oct 2013

Study assesses risk of psychiatric events in patients prescribed smoking cessation drugs

A study to assess whether patients prescribed smoking cessation drugs are at an increased risk of suicide, self-harm and treated depression compared with users of nicotine replacement therapy has found no evidence of an increased risk.

11 Oct 2013

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted and filed the company's supplemental Biologics License Application for subcutaneous use of Xolair (omalizumab) in people with Chronic Idiopathic Urticaria who remained symptomatic despite treatment with H1-antihistamine therapy at approved doses.

11 Oct 2013

Study compares effects of 2 intravenous fluids on survival for critically ill patients in ICU

Djillali Annane, M.D., Ph.D., of Raymond Poincare Hospital, Garches, France, and colleagues conducted a study to compare the effects of 2 types of intravenous fluids on survival for critically ill patients in an intensive care unit.

11 Oct 2013

Important information on effects, side effects of drugs is missing in most publications, says study

In 2012 researchers from the German Institute for Quality and Efficiency in Health Care (IQWiG) presented a study in the BMJ analysing information sources used in 16 health technology assessment (HTA) reports of drugs ("benefit assessments").

11 Oct 2013

Evidence shows vaccination pilot campaigns highly successful during 2010 cholera epidemic

The deadly cholera epidemic that rocked earthquake-shattered Haiti in 2010, claiming 8,000 lives and counting, has rallied the public health community to seek water and sewer improvements that, combined with vaccination, could prevent some 89,000 future cholera infections.

11 Oct 2013

Adding danoprevir to treatment regimen for hepatitis C patients leads to high rates of remission

The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the American Gastroenterological Association.

11 Oct 2013

Nuvo Scores $2M Payment From Galderma For Launch Of Topical Anesthetic In Brazil

...

10 Oct 2013

Alkermes' ALKS 5461 drug gets FDA Fast Track status for major depressive disorder

Alkermes plc today announced that the U.S. Food and Drug Administration has granted Fast Track status for ALKS 5461 for the adjunctive treatment of major depressive disorder in patients with an inadequate response to standard therapies.

10 Oct 2013

Heptares' StaR platform offers breakthrough solution to challenge associated with antibodies therapeutics

Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, achieved the first research milestone in its antibody therapeutics alliance with MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX), announced in February 2013.

10 Oct 2013

Physicians raise concerns about prescription drug abuse across Pennsylvania

Across Pennsylvania physicians have raised concerns about growing problems with prescription drug abuse.

10 Oct 2013

Adempas drug gets FDA approval for treatment of pulmonary hypertension

The U.S. Food and Drug Administration today approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Pulmonary hypertension is caused by abnormally high blood pressure in the arteries of the lungs.

10 Oct 2013

Researchers find no serious adverse effects of HPV vaccine in girls

Researchers at Karolinska Institutet in Sweden and their Danish colleagues have monitored HPV-vaccinated girls via patient data registries in order to examine the incidence of a wide range of diseases and thus determine if there are any serious adverse effects of the vaccine. Their results show no significant increase of the examined diseases in the vaccinated girls relative to their unvaccinated peers.

10 Oct 2013

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds boost a population of progenitor cells that can in turn repair MS-damaged nerve fibers.

10 Oct 2013

Anthem Blue Cross and Blue Shield offers tips for playing safe with prescription drugs

As we age, most of us come to depend on prescription drugs to help us live healthier, longer lives. But the very medications that we count on for better health could also land us in the hospital.

10 Oct 2013

WHO prequalifies affordable vaccine to protect children against Japanese encephalitis

An affordable vaccine to protect children against deadly Japanese encephalitis has been prequalified by the World Health Organization, paving the way to reach millions more children across Asia at risk for the disease.

10 Oct 2013

Paragon BioTeck, Horus Pharma sign distribution agreement for Ilast range of products

Paragon BioTeck, Inc. today announced that it has signed a distribution agreement with Horus Pharma for rights to supply the Ilast range of its medical-grade ocular hygiene and lid care products within the United States; it begins on an exclusive basis this month.

10 Oct 2013

Pharmaceutical News

Vitamin D supplements ineffective in preventing osteoporosis, finds study

Scientists introduce new approach to the production of synthetic heparin mimetics

Study: Statin do not improve VAP outcomes

TSRI scientists discover viable strategy for weight loss in people

Study assesses risk of psychiatric events in patients prescribed smoking cessation drugs

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

Study compares effects of 2 intravenous fluids on survival for critically ill patients in ICU

Important information on effects, side effects of drugs is missing in most publications, says study

Evidence shows vaccination pilot campaigns highly successful during 2010 cholera epidemic

Adding danoprevir to treatment regimen for hepatitis C patients leads to high rates of remission

Nuvo Scores $2M Payment From Galderma For Launch Of Topical Anesthetic In Brazil

Alkermes' ALKS 5461 drug gets FDA Fast Track status for major depressive disorder

Heptares' StaR platform offers breakthrough solution to challenge associated with antibodies therapeutics

Physicians raise concerns about prescription drug abuse across Pennsylvania

Adempas drug gets FDA approval for treatment of pulmonary hypertension

Researchers find no serious adverse effects of HPV vaccine in girls

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Anthem Blue Cross and Blue Shield offers tips for playing safe with prescription drugs

WHO prequalifies affordable vaccine to protect children against Japanese encephalitis

Paragon BioTeck, Horus Pharma sign distribution agreement for Ilast range of products

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News